Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01111916 · ClinicalTrials.gov registry record
Development Study Using Vaginal Tactile Imager
A clinical trial, sponsored by Artann Laboratories.
- Completed
- Registry status
- 31
- Enrollment target
NCT01111916: Completed study, sponsored by Artann Laboratories.
NCT01111916 is a clinical trial that has completed, run by Artann Laboratories. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01111916 has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
The objective is to evaluate and optimize tactile imaging technology in evaluation of tissue elasticity parameters in the female pelvis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
What the finished NCT01111916 record still lists
NCT01111916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01111916 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01111916 about?
NCT01111916 is a clinical study titled "Development Study Using Vaginal Tactile Imager". The objective is to evaluate and optimize tactile imaging technology in evaluation of tissue elasticity parameters in the female pelvis.
What is the current status of trial NCT01111916?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-03. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT01111916?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia